207 related articles for article (PubMed ID: 27708234)
1. Plasma and tumor levels of Linc-pint are diagnostic and prognostic biomarkers for pancreatic cancer.
Li L; Zhang GQ; Chen H; Zhao ZJ; Chen HZ; Liu H; Wang G; Jia YH; Pan SH; Kong R; Wang YW; Sun B
Oncotarget; 2016 Nov; 7(44):71773-71781. PubMed ID: 27708234
[TBL] [Abstract][Full Text] [Related]
2. Downregulation of lncRNA LINC-PINT Participates in the Recurrence of Esophageal Squamous Cell Carcinoma Possibly by Interacting miRNA-21.
Rong H; Chen B; Ma K; Wei X; Peng J; Zhu J
Cancer Biother Radiopharm; 2021 Apr; 36(3):273-279. PubMed ID: 32401035
[No Abstract] [Full Text] [Related]
3. Long intragenic non-coding RNA p53-induced transcript (LINC-PINT) as a novel prognosis indicator and therapeutic target in cancer.
He T; Yuan C; Zhao C
Biomed Pharmacother; 2021 Nov; 143():112127. PubMed ID: 34474342
[TBL] [Abstract][Full Text] [Related]
4. Long noncoding RNA LINC-PINT is inhibited in gastric cancer and predicts poor survival.
Feng H; Zhang J; Shi Y; Wang L; Zhang C; Wu L
J Cell Biochem; 2019 Jun; 120(6):9594-9600. PubMed ID: 30569513
[TBL] [Abstract][Full Text] [Related]
5. Long non-coding RNA LINC-PINT as a novel prognostic biomarker in human cancer: a meta-analysis and machine learning.
Lin J; Chen L; Zhang D
Sci Rep; 2024 Mar; 14(1):7483. PubMed ID: 38553526
[TBL] [Abstract][Full Text] [Related]
6. Long noncoding RNA
Duan J; Ma X; Shi J; Xuan Y; Wang H; Li P; Zhang Y; Fan Y; Gong H; Ma X; Pang Y; Wang L; Yan Y; Zhang X
Onco Targets Ther; 2019; 12():4729-4740. PubMed ID: 31417274
[No Abstract] [Full Text] [Related]
7. Downregulation of long non-coding RNA LINC-PINT serves as a diagnostic and prognostic biomarker in patients with non-small cell lung cancer.
Zhang C; Gong C; Li J; Tang J
Oncol Lett; 2021 Mar; 21(3):210. PubMed ID: 33552292
[TBL] [Abstract][Full Text] [Related]
8. LncRNA LINC-PINT Inhibits Cancer Cell Proliferation, Invasion, and Migration in Osteosarcoma by Downregulating miRNA-21.
Liu W
Cancer Biother Radiopharm; 2019 May; 34(4):258-263. PubMed ID: 31070482
[No Abstract] [Full Text] [Related]
9. lncRNA LINC-PINT is downregulated in melanoma and regulates cell proliferation by downregulating lncRNA BANCR.
Huang Q; Zhang D; Diao Q; Lin M
Oncol Lett; 2019 Sep; 18(3):2917-2922. PubMed ID: 31452772
[TBL] [Abstract][Full Text] [Related]
10. Large intergenic non-coding RNA-ROR as a potential biomarker for the diagnosis and dynamic monitoring of breast cancer.
Zhao T; Wu L; Li X; Dai H; Zhang Z
Cancer Biomark; 2017 Aug; 20(2):165-173. PubMed ID: 28869448
[TBL] [Abstract][Full Text] [Related]
11. Long noncoding RNA LINC-PINT regulates laryngeal carcinoma cell stemness and chemoresistance through miR-425-5p/PTCH1/SHH axis.
Yuan Z; Xiu C; Liu D; Zhou G; Yang H; Pei R; Ding C; Cui X; Sun J; Song K
J Cell Physiol; 2019 Dec; 234(12):23111-23122. PubMed ID: 31131448
[TBL] [Abstract][Full Text] [Related]
12. Long non-coding RNA LINC-PINT attenuates paclitaxel resistance in triple-negative breast cancer cells via targeting the RNA-binding protein NONO.
Chen J; Zhu M; Zou L; Xia J; Huang J; Deng Q; Xu R
Acta Biochim Biophys Sin (Shanghai); 2020 Aug; 52(8):801-809. PubMed ID: 32632453
[TBL] [Abstract][Full Text] [Related]
13. Linc-pint inhibits early stage pancreatic ductal adenocarcinoma growth through TGF-β pathway activation.
Lu H; Yang D; Zhang L; Lu S; Ye J; Li M; Hu W
Oncol Lett; 2019 May; 17(5):4633-4639. PubMed ID: 30944652
[TBL] [Abstract][Full Text] [Related]
14. Up regulation of long non-coding RNAs BACE1 and down regulation of LINC-PINT are associated with CRC clinicopathological characteristics.
Bakhtiari-Nezhad S; Rejali L; Hadizadeh M; Taleghani MY; Aghdaei HA; Young C; Khanabadi B; Nazemalhosseini-Mojarad E; Bonab MA
Mol Biol Rep; 2022 Nov; 49(11):10259-10267. PubMed ID: 36087249
[TBL] [Abstract][Full Text] [Related]
15. Role of Long Non-Coding RNA (LncRNA) LINC-PINT Downregulation in Cardiomyopathy and Retinopathy Progression Among Patients with Type 2 Diabetes.
Zha T; Su F; Liu X; Yang C; Liu L
Med Sci Monit; 2019 Nov; 25():8509-8514. PubMed ID: 31711064
[TBL] [Abstract][Full Text] [Related]
16. PINTology: A short history of the lncRNA LINC-PINT in different diseases.
Bukhari I; Khan MR; Hussain MA; Thorne RF; Yu Y; Zhang B; Zheng P; Mi Y
Wiley Interdiscip Rev RNA; 2022 Jul; 13(4):e1705. PubMed ID: 35019222
[TBL] [Abstract][Full Text] [Related]
17. LINC-PINT Suppresses the Aggressiveness of Thyroid Cancer by Downregulating miR-767-5p to Induce TET2 Expression.
Jia M; Li Z; Pan M; Tao M; Wang J; Lu X
Mol Ther Nucleic Acids; 2020 Dec; 22():319-328. PubMed ID: 33230437
[TBL] [Abstract][Full Text] [Related]
18. LINC-PINT Activates the Mitogen-Activated Protein Kinase Pathway to Promote Acute Myocardial Infarction by Regulating miR-208a-3p.
Zhu J; Gu H; Lv X; Yuan C; Ni P; Liu F
Circ J; 2018 Oct; 82(11):2783-2792. PubMed ID: 30249926
[TBL] [Abstract][Full Text] [Related]
19. LncRNA PTCSC3 Inhibits Tumor Growth and Cancer Cell Stemness in Gastric Cancer by Interacting with lncRNA Linc-pint.
Hong L; Wang H; Wang J; Wei S; Zhang F; Han J; Liu Y; Ma M; Liu C; Xu Y; Jiang D
Cancer Manag Res; 2019; 11():10393-10399. PubMed ID: 31849528
[TBL] [Abstract][Full Text] [Related]
20. Linc-PINT acted as a tumor suppressor by sponging miR-543 and miR-576-5p in esophageal cancer.
Zhang L; Chen J; Wang L; Chen L; Du Z; Zhu L; Cui M; Zhang M; Song L
J Cell Biochem; 2019 Dec; 120(12):19345-19357. PubMed ID: 31464068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
